-
Je něco špatně v tomto záznamu ?
Atypical Teratoid/Rhabdoid Tumor (AT/RT) With Molecular Features of Pleomorphic Xanthoastrocytoma
C. Thomas, A. Federico, M. Sill, S. Bens, F. Oyen, K. Nemes, PD. Johann, C. Hartmann, W. Hartmann, D. Sumerauer, V. Paterno, A. Samii, U. Kordes, R. Siebert, MC. Frühwald, W. Paulus, M. Kool, M. Hasselblatt
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- astrocytom genetika MeSH
- dítě MeSH
- gen SMARCB1 genetika MeSH
- lidé MeSH
- mladiství MeSH
- mutace MeSH
- nádory mozku genetika MeSH
- protoonkogenní proteiny B-raf genetika MeSH
- rhabdoidní nádor genetika MeSH
- teratom genetika MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Atypical teratoid/rhabdoid tumor (AT/RT) is a highly malignant central nervous system tumor predominantly occurring in infants that may also arise in older children and adults. Rare secondary AT/RT developing from other tumors such as pleomorphic xanthoastrocytoma (PXA) are on record, but AT/RT presenting with molecular features of PXA have not been described. Here, we report 3 malignant central nervous system tumors in children (10, 13, and 18 y old). All tumors were located in the temporal lobe. In 2 cases, there was no history of a low-grade precursor lesion; in 1 case anaplastic PXA had been diagnosed 3 months earlier. Histopathologically, all tumors were composed of RT cells and showed frank signs of malignancy as well as loss of nuclear SMARCB1/INI1 protein expression. Two cases displayed homozygous deletions of the SMARCB1 region while the third case showed an exon 7 mutation (c.849_850delGT; p.Met283Ilefs*77). Of note, DNA methylation profiles did not group with AT/RT or other tumor entities using the Heidelberg Brain Tumor Classifier (version v11b4). By unsupervised t-distributed stochastic neighbor embedding analysis and hierarchical clustering analysis, however, all tumors clearly grouped with PXA. Genome-wide copy number analysis revealed homozygous CDNK2A/B deletions and gains of whole chromosome 7. BRAF V600E mutations could be demonstrated in all cases. In conclusion, the possibility of AT/RT with molecular features of PXA needs to be taken into account and warrants molecular characterization of AT/RT especially in older children. Since treatments targeting mutated BRAF are available, identification of such cases may also have therapeutic consequences.
Department of Neuropathology Institute of Pathology Hannover Medical School
Department of Neurosurgery International Neuroscience Institute Hannover Germany
Department of Pediatric Hematology and Oncology University Medical Center Hamburg Eppendorf Hamburg
Division of Pediatric Neuro oncology German Cancer Research Center Heidelberg
Gerhard Domagk Institute of Pathology University Hospital Münster Münster
Institute of Human Genetics University of Ulm and Ulm University Hospital Ulm
Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024982
- 003
- CZ-PrNML
- 005
- 20211026134231.0
- 007
- ta
- 008
- 211013s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/PAS.0000000000001694 $2 doi
- 035 __
- $a (PubMed)33739782
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Thomas, Christian $u Institute of Neuropathology
- 245 10
- $a Atypical Teratoid/Rhabdoid Tumor (AT/RT) With Molecular Features of Pleomorphic Xanthoastrocytoma / $c C. Thomas, A. Federico, M. Sill, S. Bens, F. Oyen, K. Nemes, PD. Johann, C. Hartmann, W. Hartmann, D. Sumerauer, V. Paterno, A. Samii, U. Kordes, R. Siebert, MC. Frühwald, W. Paulus, M. Kool, M. Hasselblatt
- 520 9_
- $a Atypical teratoid/rhabdoid tumor (AT/RT) is a highly malignant central nervous system tumor predominantly occurring in infants that may also arise in older children and adults. Rare secondary AT/RT developing from other tumors such as pleomorphic xanthoastrocytoma (PXA) are on record, but AT/RT presenting with molecular features of PXA have not been described. Here, we report 3 malignant central nervous system tumors in children (10, 13, and 18 y old). All tumors were located in the temporal lobe. In 2 cases, there was no history of a low-grade precursor lesion; in 1 case anaplastic PXA had been diagnosed 3 months earlier. Histopathologically, all tumors were composed of RT cells and showed frank signs of malignancy as well as loss of nuclear SMARCB1/INI1 protein expression. Two cases displayed homozygous deletions of the SMARCB1 region while the third case showed an exon 7 mutation (c.849_850delGT; p.Met283Ilefs*77). Of note, DNA methylation profiles did not group with AT/RT or other tumor entities using the Heidelberg Brain Tumor Classifier (version v11b4). By unsupervised t-distributed stochastic neighbor embedding analysis and hierarchical clustering analysis, however, all tumors clearly grouped with PXA. Genome-wide copy number analysis revealed homozygous CDNK2A/B deletions and gains of whole chromosome 7. BRAF V600E mutations could be demonstrated in all cases. In conclusion, the possibility of AT/RT with molecular features of PXA needs to be taken into account and warrants molecular characterization of AT/RT especially in older children. Since treatments targeting mutated BRAF are available, identification of such cases may also have therapeutic consequences.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a astrocytom $x genetika $7 D001254
- 650 _2
- $a nádory mozku $x genetika $7 D001932
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a protoonkogenní proteiny B-raf $x genetika $7 D048493
- 650 _2
- $a rhabdoidní nádor $x genetika $7 D018335
- 650 _2
- $a gen SMARCB1 $x genetika $7 D000071796
- 650 _2
- $a teratom $x genetika $7 D013724
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Federico, Aniello $u Hopp Children's Cancer Center (KiTZ) $u Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg
- 700 1_
- $a Sill, Martin $u Hopp Children's Cancer Center (KiTZ) $u Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg
- 700 1_
- $a Bens, Susanne $u Institute of Human Genetics, University of Ulm & Ulm University Hospital, Ulm
- 700 1_
- $a Oyen, Florian $u Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg
- 700 1_
- $a Nemes, Karolina $u Swabian Childrens' Cancer Center, University Childrens' Hospital Augsburg and EU-RHAB Registry, Augsburg
- 700 1_
- $a Johann, Pascal D $u Hopp Children's Cancer Center (KiTZ) $u Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg $u Swabian Childrens' Cancer Center, University Childrens' Hospital Augsburg and EU-RHAB Registry, Augsburg
- 700 1_
- $a Hartmann, Christian $u Department of Neuropathology, Institute of Pathology, Hannover Medical School
- 700 1_
- $a Hartmann, Wolfgang $u Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Münster
- 700 1_
- $a Sumerauer, David $u Department of Pediatric Hematology and Oncology, University Hospital Motol, Charles University, 2nd Medical School, Prague, Czech Republic
- 700 1_
- $a Paterno, Vincenzo $u Department of Neurosurgery, International Neuroscience Institute, Hannover, Germany
- 700 1_
- $a Samii, Amir $u Department of Neurosurgery, International Neuroscience Institute, Hannover, Germany
- 700 1_
- $a Kordes, Uwe $u Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg
- 700 1_
- $a Siebert, Reiner $u Institute of Human Genetics, University of Ulm & Ulm University Hospital, Ulm
- 700 1_
- $a Frühwald, Michael C $u Swabian Childrens' Cancer Center, University Childrens' Hospital Augsburg and EU-RHAB Registry, Augsburg
- 700 1_
- $a Paulus, Werner $u Institute of Neuropathology
- 700 1_
- $a Kool, Marcel $u Hopp Children's Cancer Center (KiTZ) $u Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg $u Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- 700 1_
- $a Hasselblatt, Martin $u Institute of Neuropathology
- 773 0_
- $w MED00000304 $t The American journal of surgical pathology $x 1532-0979 $g Roč. 45, č. 9 (2021), s. 1228-1234
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33739782 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026134237 $b ABA008
- 999 __
- $a ok $b bmc $g 1714153 $s 1145489
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 45 $c 9 $d 1228-1234 $e 20210901 $i 1532-0979 $m The American journal of surgical pathology $n Am J Surg Pathol $x MED00000304
- LZP __
- $a Pubmed-20211013